Toxic hepatitis by consumption Herbalife® products a case report;Hepatitis aguda asociada al consumo de Herbalife® a propósito de un caso

Acta Gastroenterologica Latinoamericana

Volumn 38 M4D, Issue 4, 2008, Pages 274-277

  Chao, Sara ^a   Anders, Margarita ^a   Turbay, Maximiliano ^a   Olaiz, Emiliano ^a   Mc Cormack, Lucas ^a   Mastai, Ricardo ^a  

^a HOSPITAL ALEMÁN   (Argentina)

Author keywords

Cholestasis; Hepatitis; Hepatotoxicity; Herbal; Herbalife

Indexed keywords

HERBACEOUS AGENT; HERBALIFE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIET SUPPLEMENTATION; FEMALE; FOOD INTAKE; HEPATOGRAPHY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER FUNCTION; NUTRIENT SUPPLY; TOXIC HEPATITIS; DIETARY INTAKE; LIVER TOXICITY; ACUTE DISEASE; BIOPSY; EPHEDRA; MIDDLE AGED; PATHOLOGY;

ACUTE DISEASE; BIOPSY; DIETARY SUPPLEMENTS; EPHEDRA; FEMALE; HEPATITIS, TOXIC; HUMANS; MIDDLE AGED;

EID: 58049219887     PISSN: 03009033     EISSN: 03009033     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Winslow LC, Kroll DM. Herbs as medicine. Arch Intern Med 1998;158:2192-2199.
2. Ernest E. Herbal Medicines: where is the evidence? Growing evidence of effectiveness is counterbalances by inadequate regulation. BMJ 2000;321:395-396.
3. Duque JM, Ferreiro J, Salgueiro E, Manso G. Hepatotoxicidad relacionada con el consumo de productos adelgazantes a base de plantas. Med Clin (Barc) 2007;128:238-239. (Pubitemid 46382319)
4. Schoepfer AM, Engel A, Fattinger K, Marbet UA, Criblez D, Reichen J, Zimmermann A, Oneta CM. Herbal does not mean innocuous: ten cases of severe hepatotoxicity associated with dietary supplements from Herbalife products. J Hepatol 2007;47:521-526. (Pubitemid 47331751)
5. Elinav E, Pinsker G, Safadi R, Pappo O, Bromberg M, Anis E, Keinan-Boker L, Broide E, Ackerman Z, Kaluski DN, Lev B, Shouval D. Association between consumption of Herbalife nutritional supplements and acute hepatotoxicity. J Hepatol 2007;47:514-520. (Pubitemid 47331750)
6. Meyboom RHB. Causal or Casual? The Role of Causality Assessment in Pharmacovigilance. Drug Safety 1997;17:374-389. (Pubitemid 28017927)
7. Bernau J, Rueff B, Benhamou JP. Fulminant and subfulminant liver failure: definition and causes. Sem Liver Dis 1986;6:97-106. (Pubitemid 16010551)
8. Stickel F, Patsenker E, Schuppan D. Herbal hepatotoxicity. J Hepatol 2005;43:901-910. (Pubitemid 41414517)
9. Strader DB, Seeff LB. Zakim and Boyer Hepatology. In: Boyer TD, Wrigth TL, Manns MP, eds. Hepatotoxicity of herbal preparations. Philadelphia: Vs Saunders- Elsevier; 2006.p551-560.
10. Pond SM. Effects on the liver of chemicals encountered in the workplace. Wes J Med 2002;176:39-44.
11. Kane JA, Kane SP, Jain S. Hepatitis induced by traditional chinese herbs: posible toxic components. GUT 1995;36:146-147.
12. www.msc.es/gabinetePrensa/notaPrensa/desarrolloNota-Prensa.jsp?id=1179